Key result
Peri-operative cardiac surgery guidance recommends universal screening and elective HbA1c targets below ~7.5%.
Why the study?
Diabetes and peri-operative hyperglycaemia are associated with increased morbidity and mortality after cardiac surgery, yet specific guidance on peri-operative glycaemic management during cardiac surgery is lacking in the UK and Europe.
This narrative review provides practical recommendations to standardize peri-operative glycaemic management and universal HbA1c screening for adult cardiac surgery patients in the UK and Europe.
Answers are grounded in this paper and cite their sources.
May support universal HbA1c screening and moderate glucose targets in cardiac surgery; leaves optimal strategies open for prospective trials.
Objectives Diabetes and peri-operative hyperglycaemia are associated with increased morbidity and mortality following cardiac surgery. Despite this, specific guidance on peri-operative glycaemic management during cardiac surgery is lacking in United Kingdom (UK) and Europe. This narrative review presents evidence-based author recommendations for glycaemic control during adult cardiac surgery for those with, and without diagnosed diabetes. Methods A structured literature search was conducted using PubMed (1946–2025) and Embase (1974–2025), supplemented by Web of Science, Google Scholar, and thesis repositories. Studies reporting outcomes relating to diabetes status, HBA1C, and/or blood glucose were included. Results Our recommendations include:- evaluating HbA1c in all patients referred for cardiac surgery, regardless of diabetes status; HbA1c target of 58 mmol/mol (7.5%) for patients with diabetes having elective cardiac surgery, maintenance of intra-operative blood glucose between 6–10 mmol/L (110–180 mg/dL) for all patients, and moderate rather than intensive peri-operative glycaemic control. We recommend patients with peri-operative hyperglycaemia be assessed by in-patient diabetes specialist team if available, and/or following discharge. All cardiac surgery hospitals in time, should aim to have a dedicated cardiac surgical diabetes working group, responsible for all cardiac surgery diabetes patients, and national outcome reporting. Conclusions Lack of consensus on peri-operative diabetes management for cardiac surgery exists in the UK and Europe. Our practical recommendations, including universal HbA1c screening and glycaemic control targets, seek to standardize peri-operative management, improve clinical outcomes, and improve outcome reporting for this expanding vulnerable patient group.
No takes yet. Share an insight, caveat, or question.
Navaratnarajah et al. (2026) conducted a review in Adult cardiac surgery with or without diagnosed diabetes or peri-operative hyperglycaemia. Peri-operative glycaemic control and universal HbA1c screening vs. Intensive peri-operative glycaemic control was evaluated. Peri-operative glycaemic control recommendations for adult cardiac surgery include universal HbA1c screening, an elective HbA1c target of 58 mmol/mol, and intra-operative glucose of 6-10 mmol/L.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: